Zhen Wang

Title: Zhen Wang: Innovator in DNA Methyltransferase Research

Introduction

Zhen Wang is a prominent inventor based in Feicheng, China. He has made significant contributions to the field of molecular biology, particularly in understanding DNA methyltransferase 1 (DNMT1). His innovative work has implications for developing inhibitors that could lead to advancements in cancer treatment and other diseases.

Latest Patents

Zhen Wang holds a patent for the "DNA methyltransferase 1 transition state structure and uses thereof." This patent outlines methods and systems for obtaining inhibitors of human DNA methyltransferase 1. The methods involve designing compounds that resemble the DNMT1 transition state, showcasing Wang's expertise in biochemical research.

Career Highlights

Wang is affiliated with the Albert Einstein College of Medicine, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in therapeutic development, particularly in targeting epigenetic modifications.

Collaborations

Zhen Wang has collaborated with notable scientists such as Vern L. Schramm and Quan Du. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of DNA methylation.

Conclusion

Zhen Wang's innovative research and patent contributions highlight his role as a key figure in the study of DNA methyltransferase. His work not only advances scientific understanding but also opens new avenues for therapeutic interventions.